SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-041470
Filing Date
2024-10-18
Accepted
2024-10-17 21:34:55
Documents
5
Period of Report
2024-10-17

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 709108
2 formdef14a_001.jpg GRAPHIC 3058
3 formdef14a_002.jpg GRAPHIC 6611
4 formdef14a_003.jpg GRAPHIC 57257
5 formdef14a_004.jpg GRAPHIC 52873
  Complete submission text file 0001493152-24-041470.txt   875700
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38306 | Film No.: 241378749
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)